Table 1.
Characteristics of study population.
| Total (n = 88) | Below Median PCSK9 (n = 44) | Above Median PCSK9 (n = 44) | p-Value | |
|---|---|---|---|---|
| Age (years) | 73.6 ± 7.7 | 74.1 ± 8.9 | 72.8 ± 6.9 | 0.424 |
| Female sex (%) | 48.9 | 43.2 | 54.5 | 0.394 |
| Arterial hypertension (%) | 88.6 | 93.2 | 84.1 | 0.314 |
| Diabetes mellitus (%) | 18.2 | 15.9 | 20.5 | 0.783 |
| Heart failure (%) | 14.8 | 15.9 | 13.6 | 0.764 |
| Prior cerebrovascular events (%) | 12.6 | 15.9 | 9.3 | 0.521 |
| Prior cardiac events (%) | 22.7 | 25.0 | 20.5 | 0.800 |
| Antiplatelet therapy (%) | 00.0 | |||
| Statins (%) | 42.0 | 47.7 | 36.4 | 0.388 |
| Proton pomp inhibitors (%) | 43.0 | 38.6 | 47.6 | 0.514 |
| CHA2DS2-VASc score | 3.46 ± 1.42 | 3.64 ± 1.50 | 3.34 ± 1.40 | 0.341 |